Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity
November 11, 2021
A recent study shows that a new A.30 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can evade vaccine-induced antibodies and might spread outside the lungs extraordinarily well. This finding holds important implications for our public health response.
Back »
